Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Retinal Vein Occlusion Market Growth in 2025?
The market size for retinal vein occlusion has seen a swift expansion in recent times. The market, which was valued at $15.43 billion in 2024, is projected to jump to $17.21 billion in 2025, recording a compound annual growth rate (CAGR) of 11.6%. The historic growth can be credited to factors such as an aging population, advancements in diagnostic imaging, progress in pharmaceuticals, and a rise in the prevalence of diabetes.
What Is the Forecast for the Retinal Vein Occlusion Market Size Through 2029?
The market size for retinal vein occlusion is poised for considerable expansion in the upcoming years. It is projected to surge to a valuation of $25.66 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.5%. The anticipated growth during the forecast period is due largely to new treatment methodologies, the advent of telemedicine and remote supervision, custom-tailored medication, and regulatory sanctioning. The forecast period will also witness prominent trends including non-invasive therapeutic alternatives, advancements in gene therapy, patient-focused healthcare, and digital health apparatus.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13058&type=smp
What are the Key Market Players in Retinal Vein Occlusion Market and How They’re Evolving?
Major companies operating in the retinal vein occlusion market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Amgen Inc., Allergan PLC, Regeneron Pharmaceuticals Inc., Biogen Idec Inc., Vertex Pharmaceuticals Inc., Bausch Health Companies Inc., Carl Zeiss AG, Santen Pharmaceutical Co. Ltd., Lumenis Ltd., Coherus Biosciences Inc., Genentech Inc., Topcon Corporation, Nidek Co. Ltd., IRIDEX Corporation, Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Kodiak Sciences Inc., Ellex Medical Lasers Ltd., Adverum Biotechnologies Inc., Avik Pharmaceutical Limited (Avik), Outlook Therapeutics Inc., Annexin Pharmaceuticals AB, Ingenia Therapeutics Inc.
What Are the Primary Growth Drivers in the Retinal Vein Occlusion Market?
The ocular medicine delivery market is anticipated to grow, fueled by the increasing prevalence of numerous eye conditions that seem to be on the rise. These involve conditions that affect eyes, vision or the structures surrounding the eyes, thereby also influencing the renal vein occlusion market. An increased incidence of renal vein occlusion prompts the need for innovative diagnostics and treatments. For instance, World Health Organization’s figures from March 2023 project that a global population of 2.2 billion will experience near- or far-sighted impairment, with cataracts (94 million) and uncorrected refractive issues (88.4 million) being the main culprits. It also cites glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases) and trachoma (2 million cases) as leading causes of vision loss. Hence, the rise in the occurrence of these eye disorders will fuel the growth of the retinal vein occlusion market. A notable increase in glaucoma cases is expected to push the retinal vein occlusion market’s growth further. Characterized by high intraocular pressure that can damage the optic nerve and potentially lead to loss of vision or blindness if untreated, glaucoma’s growing incidence contributes significantly to the expansion of the retinal vein occlusion market, underlining the need for effective strategies for prevention and management. The aim of these strategies is to mitigate the risk of retinal vein occlusion and uplift the overall quality of life. BrightFocus Foundation, a United States based nonprofit organization divulged in October 2022, nearly 80 million people globally are affected by glaucoma, a figure that’s projected to escalate to over 111 million by 2040. Consequently, the glaucoma incidence surge will drive the robust growth of the optic atrophy management market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13058&type=smp
What Are the Leading Segments in the Global Retinal Vein Occlusion Industry?
The retinal vein occlusion market covered in this report is segmented –
1) By Type: Branch Retinal Artery Occlusion, Central Retinal Vein Occlusion
2) By Condition: Non-Ischemic, Ischemic
3) By Diagnosis: Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography
4) By Treatment: Antivascular Endothelial Growth Factor, Corticosteroid Drugs, Laser Retinal Photocoagulation
5) By End User: Hospitals And Clinics, Research And Academics Centers, Other End-Users
Subsegments:
1) By Branch Retinal Artery Occlusion: Non-ischemic Branch Retinal Artery Occlusion, Ischemic Branch Retinal Artery Occlusion
2) By Central Retinal Vein Occlusion: Non-ischemic Central Retinal Vein Occlusion, Ischemic Central Retinal Vein Occlusion
What Are the Key Market Trends in the Retinal Vein Occlusion Industry?
Firms in the retinal vein occlusion market are adopting innovative strategies to improve patient care and treatment results, and maintain their market standing. Progress in drug discovery could broaden treatment choices for RVO, ensuring more specific and effective therapy. For example, in April 2023, Iridex Corporation, a US-based firm specializing in ophthalmic medical technology, introduced the advanced Iridex PASCAL. The ground-breaking platform incorporates a state-of-the-art technology bundle, including rapid and precise pattern scanning capabilities, endpoint management technology, a pattern scanning laser trabeculoplasty, and micropulse technology in a more streamlined, ergonomically designed integrated laser platform to deliver tailored care for patients suffering from retinal disease.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-global-market-report
What Is the Regional Outlook for the Retinal Vein Occlusion Market?
North America was the largest region in the retinal vein occlusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in retinal vein occlusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13058
This Report Delivers Insight On:
1. How big is the retinal vein occlusion market, and how is it changing globally?
2. Who are the major companies in the retinal vein occlusion market, and how are they performing?
3. What are the key opportunities and risks in the retinal vein occlusion market right now?
4. Which products or customer segments are growing the most in the retinal vein occlusion market?
5. What factors are helping or slowing down the growth of the retinal vein occlusion market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model